INTERNATIONAL PATENT: BENNU BIOTHERAPEUTICS (SHANGHAI) CO., LTD., 毕诺济（上海）生物技术有限公司 FILES APPLICATION FOR "GENE-EDITED TUMOR-INFILTRATING LYMPHOCYTES AND T CELL RECEPTOR-ENGINEERED T CELLS AND USE THEREOF IN IMMUNOTHERAPY"

Posted On: 2025-10-26

GENEVA, Oct. 26 -- BENNU BIOTHERAPEUTICS (SHANGHAI) CO., LTD. (Building 1, Floor 3, 400 Fangchun RD, China (Shanghai) Pilot Free Trade ZonePudong New Area, Shanghai 201210), 毕诺济（上海）生物技术有限公司 (中国上海市浦东新区自由贸易试验区芳春路400号1幢3层) filed a patent application (PCT/CN2024/136659) for "GENE-EDITED TUMOR-INFILTRATING LYMPHOCYTES AND T CELL RECEPTOR-ENGINEERED T CELLS, AND USE THEREOF IN IMMUNOTHERAPY" on Dec 04, 2024. With publication no. WO/2025/218187, the details related to the patent application wa...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: BENNU BIOTHERAPEUTICS (SHANGHAI) CO., LTD., 毕诺济（上海）生物技术有限公司 FILES APPLICATION FOR "GENE-EDITED TUMOR-INFILTRATING LYMPHOCYTES AND T CELL RECEPTOR-ENGINEERED T CELLS AND USE THEREOF IN IMMUNOTHERAPY"